Outset Medical, Inc. (NASDAQ:OM – Get Free Report) CFO Nabeel Ahmed sold 34,288 shares of Outset Medical stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $0.80, for a total value of $27,430.40. Following the completion of the transaction, the chief financial officer now owns 258,869 shares in the company, valued at approximately $207,095.20. This represents a 11.70 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Nabeel Ahmed also recently made the following trade(s):
- On Monday, January 13th, Nabeel Ahmed sold 29,031 shares of Outset Medical stock. The shares were sold at an average price of $0.81, for a total transaction of $23,515.11.
- On Tuesday, January 7th, Nabeel Ahmed sold 1,835 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total transaction of $2,367.15.
- On Friday, November 15th, Nabeel Ahmed sold 4,221 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $3,376.80.
Outset Medical Trading Down 3.3 %
Outset Medical stock opened at $0.78 on Thursday. The business has a 50 day moving average of $1.01 and a 200-day moving average of $1.28. Outset Medical, Inc. has a 1 year low of $0.44 and a 1 year high of $5.22. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12.
Hedge Funds Weigh In On Outset Medical
Analysts Set New Price Targets
Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $3.00 price target on shares of Outset Medical in a report on Tuesday, January 7th.
About Outset Medical
Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
Featured Stories
- Five stocks we like better than Outset Medical
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Oracle Announces Game-Changing News for the AI Industry
- What is the Dow Jones Industrial Average (DJIA)?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What is a Bond Market Holiday? How to Invest and Trade
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.